Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solterbeck

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|September 4, 2025
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimizationPhoebe Joy Ho, Vinay Vanguru, Cale S Burge, et al.
Journal of Gastrointestinal Cancer|January 16, 2026
A Prospective, Cross-Sectional, Multicenter Study Evaluating a Multi-Target Blood Protein in Vitro Diagnostic Test for Colorectal CancerEmily Y He, Guy A van Hazel, Andrew M Sloss, et al.
Leukemia Research|March 2, 2018
Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift studyDevendra Hiwase, Peter Tan, James D'Rozario, et al.
Blood|October 7, 2022
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversionYandong Shen, Jane A Freeman, Juliette Holland, et al.
British Journal of Haematology|December 28, 2021
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunityYandong Shen, Jane A Freeman, Juliette Holland, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Frontiers in Oncology|September 4, 2025
Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma-importance of pre-CAR-T optimizationPhoebe Joy Ho, Vinay Vanguru, Cale S Burge, et al.
Journal of Gastrointestinal Cancer|January 16, 2026
A Prospective, Cross-Sectional, Multicenter Study Evaluating a Multi-Target Blood Protein in Vitro Diagnostic Test for Colorectal CancerEmily Y He, Guy A van Hazel, Andrew M Sloss, et al.
Leukemia Research|March 2, 2018
Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift studyDevendra Hiwase, Peter Tan, James D'Rozario, et al.
Blood|October 7, 2022
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversionYandong Shen, Jane A Freeman, Juliette Holland, et al.
British Journal of Haematology|December 28, 2021
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunityYandong Shen, Jane A Freeman, Juliette Holland, et al.
Pageof 3